AAAAAA

   
Results: 1-13 |
Results: 13
Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum
Authors: Houze, P Deschamps, F Dombret, H Bousquet, B Gourmel, B
Citation: P. Houze et al., Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum, J CHROMAT B, 754(1), 2001, pp. 185-192
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse
Authors: Sievers, EL Larson, RA Stadtmauer, EA Estey, E Lowenberg, B Dombret, H Karanes, C Theobald, M Bennett, JM Sherman, ML Berger, MS Eten, CB Loken, MR van Dongen, JJM Bernstein, ID Appelbaum, FR
Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
Authors: Fenaux, P Chevret, S Guerci, A Fegueux, N Dombret, H Thomas, X Sanz, M Link, H Maloisel, F Gardin, C Bordessoule, D Stoppa, AM Sadoun, A Muus, P Wandt, H Mineur, P Whittaker, JA Fey, M Daniel, MT Castaigne, S Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation
Authors: Thomas, X Dombret, H Cordonnier, C Pigneux, A Gardin, C Guerci, A Vekhoff, A Sadoun, A Stamatoullas, A Fegueux, N Maloisel, F Cahn, JY Reman, O Gratecos, N Berthou, C Huguet, F Kotoucek, P Travade, P Buzyn, A de Revel, T Vilque, JP Naccache, P Chomienne, C Degos, L Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
Authors: de Botton, S Chevret, S Sanz, M Dombret, H Thomas, X Guerci, A Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Geiser, K Hess, U Maloisel, F Castaigne, S Preudhomme, C Chomienne, C Degos, L Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
Authors: Adida, C Recher, C Raffoux, E Daniel, MT Taksin, AL Rousselot, P Sigaux, F Degos, L Altieri, DC Dombret, H
Citation: C. Adida et al., Expression and prognostic significance of survivin in de novo acute myeloid leukaemia, BR J HAEM, 111(1), 2000, pp. 196-203
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
Authors: Adida, C Haioun, C Gaulard, P Lepage, E Morel, P Briere, J Dombret, H Reyes, F Diebold, J Gisselbrecht, C Salles, G Altieri, DC Molina, TJ
Citation: C. Adida et al., Prognostic significance of survivin expression in diffuse large B-cell lymphomas, BLOOD, 96(5), 2000, pp. 1921-1925
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment
Authors: Bastie, JN Cazals-Hatem, D Daniel, MT D'Agay, MF Rabian, CL Glaisner, S Noel-Walter, MP Dabout, D Flandrin, G Dombret, H Poisson, D Degos, L Castaigne, S
Citation: Jn. Bastie et al., Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment, LEUK LYMPH, 35(5-6), 1999, pp. 555-565
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature
Authors: Pautier, P Devidas, A Delmer, A Dombret, H Sutton, L Zini, JM Nedelec, G Molina, T Marolleau, JP Brice, P
Citation: P. Pautier et al., Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature, LEUK LYMPH, 32(5-6), 1999, pp. 545-552
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
Authors: Thomas, X Fenaux, P Dombret, H Delair, S Dreyfus, F Tilly, H Vekhoff, A Cony-Makhoul, P Leblond, V Troussard, X Cordonnier, C de Revel, T Simon, M Nicolini, F Stoppa, AM Janvier, M Bordessoule, D Rousselot, P Ffrench, M Marie, JP Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
Authors: Fenaux, P Chastang, C Chevret, S Sanz, M Dombret, H Archimbaud, E Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Maloisel, F Castaigne, S Preudhomme, C Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia
Authors: Archimbaud, E Ottmann, OG Yin, JAL Lechner, K Dombret, H Sanz, MA Heil, G Fenaux, P Brugger, W Barge, A O'Brien-Ewen, C Matcham, J Hoelzer, D
Citation: E. Archimbaud et al., A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3694-3701
Granulocyte colony-stimulating factor in combination with intensive chemotherapy in the treatment of acute myeloid leukemia
Authors: Dombret, H
Citation: H. Dombret, Granulocyte colony-stimulating factor in combination with intensive chemotherapy in the treatment of acute myeloid leukemia, LEUK RES, 22(12), 1998, pp. 1137-1142
Risultati: 1-13 |